A flow cytometry analysis of immune composition of human gliomas with a different IDH1 status demonstrated that human IDH1-mut gliomas have significantly lower infiltration of CD45+ immune cells, including microglia, macrophages, dendritic cells, B cells, and T cells, compared with IDH1-wt gliomas. The gene discussed is IDH1; the disease is central nervous system cancer.